Earnings Preview: YMAB to Report Financial Results Pre-market on November 08

$Y-mAbs Therapeutics(YMAB.US)$ is scheduled to release its financial results pre-market on November 08 ET. Earnings PreviewAnalysts estimate $Y-mAbs Therapeutics(YMAB.US)$ to post revenue of USD23.26

Futu News09:00

Y-mAbs Therapeutics And Nobelpharma Entered Into An Exclusive License And Distribution Agreement For The Development And Commercialization In Japan Of Danyelza For Relapsed/Refractory High-risk Neuroblastoma And Potentially Relapsed Osteosarcoma,...

BenzingaNov 4 20:39

Express News | Y-mAbs Therapeutics Inc - to Receive $2 Mln Upfront, up to $31 Mln in Milestone Payments

BreakingsNov 4 20:35

Express News | Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for Danyelza® (Naxitamab-Gqgk) in Japan

BreakingsNov 4 20:35

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

Zacks Nov 1 21:15

JonesTrading Maintains Y-mAbs Therapeutics(YMAB.US) With Buy Rating, Maintains Target Price $23

Futu NewsOct 31 23:31 · Ratings